First Wave BioPharma Inc Live Share Price Today, Share Analysis and Chart

Name: First Wave BioPharma Inc: Is Infosys Ltd. worth buying?
Item: First Wave BioPharma Inc
Rating: 0.46575
Author: Trendlyne DVM scores

about

Entero Therapeutics Inc is a late clinical-stage biopharmaceutical company focused on the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases. The company's programs address unmet needs in GI health and include: latiglu...

0.48 -0.01 (-2.04%)

30.43% Fall from 52W High

348.4K

XNAS Volume

High vol.+gain this week

XNAS 14 Jul, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

0.0 / 100

Technically Bearish

18.6 / 100

No estimates available

First Wave BioPharma Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

First Wave BioPharma Inc Live Share Price Today, Share Analysis and Chart

Entero Therapeutics Inc is a late clinical-stage biopharmaceutical company focused on the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases. The company's programs address unmet needs in GI health and include: latiglu...

30.43% Fall from 52W High

High vol.+gain this week

SWOT Analysis

First Wave BioPharma Inc Live Price Chart